Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Kilpatrick, GJ' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 27 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Dautzenberg, FM; Kilpatrick, GJ; Hauger, RL; Moreau, JL
      Molecular biology of the CRH receptors - in the mood

      PEPTIDES
    2. Dautzenberg, FM; Wichmann, J; Higelin, J; Py-Lang, G; Kratzeisen, C; Malherbe, P; Kilpatrick, GJ; Jenck, F
      Pharmacological characterization of the novel nonpeptide orphanin FQ/nociceptin receptor agonist Ro 64-6198: Rapid and reversible desensitization of the ORL1 receptor in vitro and lack of tolerance in vivo

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    3. Dautzenberg, FM; Huber, G; Higelin, J; Py-Lang, G; Kilpatrick, GJ
      Evidence for the abundant expression of arginine 185 containing human CRF2alpha receptors and the role of position 185 for receptor-ligand selectivity

      NEUROPHARMACOLOGY
    4. Ardati, A; Goetschy, V; Gottowick, J; Henriot, S; Valdenaire, O; Deuschle, U; Kilpatrick, GJ
      Human CRF2 alpha and beta splice variants: pharmacological characterization using radioligand binding and a luciferase gene expression assay

      NEUROPHARMACOLOGY
    5. Dautzenberg, FM; Kilpatrick, GJ; Wille, S; Hauger, RL
      The ligand-selective domains of corticotropin-releasing factor type 1 and type 2 receptor reside in different extracellular domains: Generation of chimeric receptors with a novel ligand-selective profile

      JOURNAL OF NEUROCHEMISTRY
    6. Henriot, S; Dautzenberg, FM; Kilpatrick, GJ
      Urocortin: slower dissociation than corticotropin releasing factor from the CRF binding protein

      EUROPEAN JOURNAL OF PHARMACOLOGY
    7. ARDATI A; GOTTOWIK J; HENRIOT S; CLERC RG; KILPATRICK GJ
      PHARMACOLOGICAL CHARACTERIZATION OF THE RECOMBINANT HUMAN CRF BINDING-PROTEIN USING A SIMPLE ASSAY

      Journal of neuroscience methods
    8. GOTTOWIK J; GOETSCHY V; HENRIOT S; KITAS E; FLUHMAN B; CLERC RG; MOREAU JL; MONSMA FJ; KILPATRICK GJ
      LABELING OF CRF1 AND CRF2 RECEPTORS USING THE NOVEL RADIOLIGAND, [H-3] UROCORTIN

      Neuropharmacology
    9. JENCK F; MOREAU JL; MARTIN JR; KILPATRICK GJ; REINSCHEID RK; MONSMA FJ; NOTHACKER HP; CIVELLI O
      ORPHANIN FQ ACTS AS AN ANXIOLYTIC TO ATTENUATE BEHAVIORAL-RESPONSES TO STRESS

      Proceedings of the National Academy of Sciences of the United Statesof America
    10. MURRAY PJ; HELDEN RM; JOHNSON MR; ROBERTSON GM; SCOPES DIC; STOKES M; WADMAN S; WHITEHEAD JWF; HAYES AG; KILPATRICK GJ; LARGE C; STUBBS CM; TURPIN MP
      NOVEL 6-SUBSTITUTED 2-AMINOTETRALINS WITH POTENT AND SELECTIVE AFFINITY FOR THE DOPAMINE D-3 RECEPTOR

      Bioorganic & medicinal chemistry letters
    11. GARDNER CJ; ARMOUR DR; BEATTIE DT; GALE JD; HAWCOCK AB; KILPATRICK GJ; TWISSELL DJ; WARD P
      GR205171 - A NOVEL ANTAGONIST WITH HIGH-AFFINITY FOR THE TACHYKININ NK1 RECEPTOR, AND POTENT BROAD-SPECTRUM ANTIEMETIC ACTIVITY

      Regulatory peptides
    12. BOUNTRA C; GALE JD; GARDNER CJ; JORDAN CC; KILPATRICK GJ; TWISSELL DJ; WARD P
      TOWARDS UNDERSTANDING THE ETIOLOGY AND PATHOPHYSIOLOGY OF THE EMETIC REFLEX - NOVEL APPROACHES TO ANTIEMETIC DRUGS

      Oncology
    13. BROWN JD; OSHAUGHNESSY CT; KILPATRICK GJ; SCOPES DIC; BESWICK P; CLITHEROW JW; BARNES JC
      CHARACTERIZATION OF THE SPECIFIC BINDING OF THE HISTAMINE H-3 RECEPTOR ANTAGONIST RADIOLIGAND [H-3] GR168320

      European journal of pharmacology
    14. MURRAY PJ; HARRISON LA; JOHNSON MR; ROBERTSON GM; SCOPES DIC; BULL DR; GRAHAM EA; HAYES AG; KILPATRICK GJ; DENDAAS I; LARGE C; SHEEHAN MJ; STUBBS CM; TURPIN MP
      A NOVEL SERIES OF ARYLPIPERAZINES WITH HIGH-AFFINITY AND SELECTIVITY FOR THE DOPAMINE D-3 RECEPTOR

      Bioorganic & medicinal chemistry letters
    15. KILPATRICK GJ; HAGAN RM; GALE JD
      5-HT3 AND 5-HT4 RECEPTORS IN TERMINAL REGIONS OF THE MESOLIMBIC SYSTEM

      Behavioural brain research
    16. PERREN MJ; ROGERS H; MASON GS; BULL DR; KILPATRICK GJ
      A PHARMACOLOGICAL COMPARISON OF [H-3] GRANISETRON BINDING-SITES IN BRAIN AND PERIPHERAL-TISSUES OF THE MOUSE

      Naunyn-Schmiedeberg's archives of pharmacology
    17. GARDNER CJ; TWISSELL DJ; DALE TJ; GALE JD; JORDAN CC; KILPATRICK GJ; BOUNTRA C; WARD P
      THE BROAD-SPECTRUM ANTIEMETIC ACTIVITY OF THE NOVEL NONPEPTIDE TACHYKININ NK1 RECEPTOR ANTAGONIST GR203040

      British Journal of Pharmacology
    18. GARDNER CJ; TWISSELL DJ; GALE JD; KILPATRICK GJ; WARD P
      EFFECTS OF RACEMIC CP-99,994, A TACHYKININ NK1 RECEPTOR ANTAGONIST, ON MOTION-INDUCED EMESIS IN SUNCUS-MURINUS

      British Journal of Pharmacology
    19. CLAPHAM J; KILPATRICK GJ
      THIOPERAMIDE, THE SELECTIVE HISTAMINE-H-3 RECEPTOR ANTAGONIST, ATTENUATES STIMULANT-INDUCED LOCOMOTOR-ACTIVITY IN THE MOUSE

      European journal of pharmacology
    20. PERREN MJ; BULL DR; MULLINGS JD; KILPATRICK GJ
      EVALUATION OF THE MOUSE ISOLATED SUPERFUSED DISTAL COLON AS A FUNCTIONAL 5-HT3 RECEPTOR-CONTAINING PREPARATION

      British Journal of Pharmacology
    21. ROGERS H; ABRAMS CJ; KILPATRICK GJ
      EX-VIVO BINDING OF 5-HT3 ANTAGONISTS TO 5-HT3 RECEPTORS IN THE RAT ENTORHINAL CORTEX AND COLON

      British Journal of Pharmacology
    22. BROWN JD; OSHAUGHNESSY CT; KILPATRICK GJ; SCOPES DIC; BESWICK P; CLITHEROW JW; BARNES JC
      CHARACTERIZATION OF THE SPECIFIC BINDING OF THE HISTAMINE H-3 RECEPTOR ANTAGONIST RADIOLIGAND [H-3] GR168320

      British Journal of Pharmacology
    23. LUMMIS SCR; SEPULVEDA MI; KILPATRICK GJ; BAKER J
      CHARACTERIZATION OF [H-3] META-CHLOROPHENYLBIGUANIDE BINDING TO 5-HT(3) RECEPTORS IN N1E-115 NEUROBLASTOMA-CELLS

      European journal of pharmacology
    24. STEWARD LJ; WEST KE; KILPATRICK GJ; BARNES NM
      LABELING OF 5-HT(3) RECEPTOR RECOGNITION SITES IN THE RAT-BRAIN USINGTHE AGONIST RADIOLIGAND [H-3] META-CHLOROPHENYLBIGUANIDE

      European journal of pharmacology
    25. CLAPHAM J; DENNES RP; KILPATRICK GJ; BARNES JC
      ABILITY OF THE SELECTIVE HISTAMINE H-3 RECEPTOR ANTAGONIST THIOPERAMIDE TO IMPROVE SHORT-TERM-MEMORY AND REVERSAL-LEARNING IN THE RAT

      British Journal of Pharmacology
    26. GROSSMAN CJ; KILPATRICK GJ; BUNCE KT
      DEVELOPMENT OF A RADIOLIGAND BINDING ASSAY FOR 5-HT(4)-RECEPTORS IN GUINEA-PIG AND RAT-BRAIN

      British Journal of Pharmacology
    27. HAGAN RM; KILPATRICK GJ; TYERS MB
      INTERACTIONS BETWEEN 5-HT(3) RECEPTORS AND CEREBRAL DOPAMINE FUNCTION- IMPLICATIONS FOR THE TREATMENT OF SCHIZOPHRENIA AND PSYCHOACTIVE SUBSTANCE-ABUSE

      Psychopharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 17/02/20 alle ore 08:15:47